Grant & Award Opportunities - Stand Up To Cancer

Grant & Award Opportunities

Stand Up To Cancer (SU2C) grants and awards fund cancer research projects that address critical problems in patient care and deliver near-term patient benefit through both individual and collaborative teams of expert investigators.

We are also committed to actively changing the health disparities landscape by supporting research and clinical trials that will develop successful strategies, measurable outcomes, and robust outreach to historically underrepresented racial and ethnic minority populations.

Core Principles

Patients can’t wait for new breakthroughs so SU2C does not operate on traditional grant cycles; rather we open Request For Applications (RFAs) as soon as funds are available. The core principles that guide our application selection process include:

  • Maximizing innovation while minimizing bureaucracy
  • Collaboration over competition
  • Advancing Health Equity in project goals and in grantee team makeup
  • Team environment to facilitate information sharing
  • Goal-oriented projects with defined milestones and deliverables
  • Regular progress reviews

Stand Up To Cancer is committed to eliminating barriers of access to new treatments for all cancer patients by harnessing the promise of precision medicine inclusive of diverse patient populations. We support clinical trials and research studies that have developed successful strategies, measurable outcomes, and robust outreach plans to include historically underrepresented racial and ethnic minority populations. We have developed application resources for incorporating health equity principles into research projects.

Open Applications

Stand Up To Cancer strongly encourages novel, collaborative, and high-impact proposals. Proposals submitted in response to Requests for Applications (RFAs) are rigorously reviewed, and the most promising, exciting projects are selected by blue ribbon committees.

SU2C Gastroesophageal Cancer Dream Team Grant Program

The SU2C Gastroesophageal Cancer Dream Team Grant Program endeavors to bring new therapies to clinical trials for the treatment of gastroesophageal cancer in diverse populations. Applications are encouraged from researchers who propose approaches or screens to identify new cancer cell intrinsic therapeutic targets, to target the tumor microenvironment, to utilize new cellular therapies (including NK cell based therapies) or to investigate resistance to immunotherapy in gastroesophageal cancer. Teams may apply for total support up to $6,000,000 over a 4-year term. The Letter of Intent deadline is Monday, June 27, 2022. Teams invited to submit Full Applications will be notified on or before Wednesday, July 27, 2022. The deadline for Full Applications is Thursday, October 6, 2022.

For more information and to apply, go to Proposal Central, search Stand Up To Cancer under Grant Opportunities, and begin the application process.

If you have questions, please contact proposals@su2c.org.

SU2C Diversity in Early Development Clinical Trials Program

Stand Up To Cancer (SU2C) invites applications for the SU2C Diversity in Early Development Clinical Trials Program. The Diversity in Early Development Clinical Trials Team will support four grantee teams from distinct targeted regions and/or Institutions to increase diversity among participants in Phase 1 and Phase 2 cancer clinical trials. This program is supported by a grant from Janssen Research & Development, LLC.

For more information and to apply, click Apply Now.  You will then need to create an account on Proposal Central. Once logged into your account, you can search Stand Up To Cancer under Grant Opportunities and begin your application process.

Upcoming Areas of Interest

SU2C is interested in funding innovative research that has the potential to deliver life-saving results to all patients near-term, and supporting collaborations that focus on research in specific diseases or therapeutic approaches.

Areas of interest are best identified by our scientific leadership, strategic imperatives, and existing and emerging collaborations are ripe for breakthroughs that provide the most benefit to patients in the near term.

RESEARCH WE FUND

When new areas of research are identified that could have significant patient impact and potential for breakthrough, SU2C acts quickly to push proposals in these areas from concept to reality. SU2C’s research teams study many cancer types, with a focus on today’s most innovative areas of cancer detection and therapy.

SU2C FUNDING BY DISEASE TYPE

Pancreatic Cancer (19.5%)Leukemia/Leukaemia (7%)Lung Cancer (14.5%)Melanoma (5%)Breast Cancer (13%)Brain Tumor (3%)Not-Site Specific Cancer (10%)Ovarian Cancer (3%)Colon and Rectal Cancer (7%)Endometrial (2%)Prostate Cancer (8%)*Other Cancers (6%)

*Other Cancers (6%)

NeuroblastomaGenital System, MaleKidneyMyelomaNon-Hodgkin’s LymphomaGenital System, FemaleUrinary TractAnal CancerLiverSarcoma (soft-tissue)Cervical CancerLaryngealBone CancerGastrointestinalPharyngeal

Progress against one cancer is progress against all cancers.
See what SU2C scientists are working on now.

VIEW OUR RESEARCH PORTFOLIO

STAY UP TO DATE WITH SU2C RESEARCH OPPORTUNITIES

If you are interested in research funding opportunities, and being a part of SU2C’s scientific community, sign up for updates and follow @SU2CScience on Twitter.

   Please leave this field empty
Please validate the captcha
Loading

For more information on our grants, or your application, please email proposals@su2c.org.

Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.